Gene expression profiling of human plasma cell differentiation and classification of multiple myeloma based on similarities to distinct stages of late-stage B-cell development.

To identify genes linked to normal plasma cell (PC) differentiation and to classify multiple myeloma (MM) with respect to the expression patterns of these genes, we analyzed global mRNA expression in CD19-enriched B cells (BCs) from 7 tonsils, CD138-enriched PCs from 11 tonsils, 31 normal bone marrow samples, and 74 MM bone marrow samples using microarrays interrogating 6800 genes. Hierarchical clustering analyses with 3288 genes clearly segregated the 4 cell types, and chi-square and Wilcoxin rank sum tests (P <.0005) identified 359 and 500 previously defined and novel genes that distinguish tonsil BCs from tonsil PCs (early differentiation genes [EDGs]), and tonsil PCs from bone marrow PCs (late differentiation genes [LDGs]), respectively. MM as a whole was found to have dramatically variable expression of EDGs and LDGs, and one-way analysis of variance (ANOVA) was used to identify the most variable EDGs (vEDGs) and LDGs (v1LDG and v2LDG). Hierarchical cluster analysis with these genes revealed that previously defined MM gene expression subgroups (MM1-MM4) could be linked to one of the 3 normal cell types. Clustering with 30 vEDGs revealed that 13 of 18 MM4 cases clustered with tonsil BCs (P =.000 05), whereas 14 of 15 MM3 cases clustered with tonsil PCs when using 50 v1LDG (P =.000 008), and 14 of 20 MM2 cases clustered with bone marrow PCs when using 50 v2LDG (P =.000 09). MM1 showed no significant linkage with normal cell types studied. Thus, genes whose expression is linked to distinct transitions in late-stage B-cell differentiation can be used to classify MM.

[1]  A. Campos-Caro,et al.  The heterogeneity shown by human plasma cells from tonsil, blood, and bone marrow reveals graded stages of increasing maturity, but local profiles of adhesion molecule expression. , 2002, Blood.

[2]  J. Downing,et al.  Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling. , 2002, Cancer cell.

[3]  John Crowley,et al.  Global gene expression profiling of multiple myeloma, monoclonal gammopathy of undetermined significance, and normal bone marrow plasma cells. , 2002, Blood.

[4]  David Botstein,et al.  Relation of Gene Expression Phenotype to Immunoglobulin Mutation Genotype in B Cell Chronic Lymphocytic Leukemia , 2001, The Journal of experimental medicine.

[5]  Y. Tu,et al.  Gene Expression Profiling of B Cell Chronic Lymphocytic Leukemia Reveals a Homogeneous Phenotype Related to Memory B Cells , 2001, The Journal of experimental medicine.

[6]  K. Calame,et al.  Plasma cells: finding new light at the end of B cell development , 2001, Nature Immunology.

[7]  Michael P. Lisanti,et al.  Emerging Themes in Lipid Rafts and Caveolae , 2001, Cell.

[8]  Neal N. Iwakoshi,et al.  Plasma cell differentiation requires the transcription factor XBP-1 , 2001, Nature.

[9]  L. Garrett-Sinha,et al.  PU.1 exhibits partial functional redundancy with Spi-B, but not with Ets-1 or Elf-1. , 2001, Blood.

[10]  D. Eberhard,et al.  Pax5 Determines the Identity of B Cells from the Beginning to the End of B-lymphopoiesis , 2001, International reviews of immunology.

[11]  G. Cattoretti,et al.  Commitment of B Lymphocytes to a Plasma Cell Fate Is Associated with Blimp-1 Expression In Vivo1 , 2000, The Journal of Immunology.

[12]  K. Toellner,et al.  Intrinsic Constraint on Plasmablast Growth and Extrinsic Limits of Plasma Cell Survival , 2000, The Journal of experimental medicine.

[13]  B. Barlogie,et al.  High incidence of chromosome 13 deletion in multiple myeloma detected by multiprobe interphase FISH. , 2000, Blood.

[14]  Ash A. Alizadeh,et al.  Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling , 2000, Nature.

[15]  J. Mesirov,et al.  Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. , 1999, Science.

[16]  R. Bataille,et al.  Reactive plasmacytoses are expansions of plasmablasts retaining the capacity to differentiate into plasma cells. , 1999, Blood.

[17]  D. Botstein,et al.  Cluster analysis and display of genome-wide expression patterns. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[18]  N Muthusamy,et al.  The Ets-1 transcription factor is required for the development of natural killer cells in mice. , 1998, Immunity.

[19]  A. M. Morrison,et al.  Loss- and gain-of-function mutations reveal an important role of BSAP (Pax-5) at the start and end of B cell differentiation. , 1998, Seminars in immunology.

[20]  G. Kelsoe,et al.  In Situ Studies of the Primary Immune Response to (4-Hydroxy-3-Nitrophenyl)Acetyl. V. Affinity Maturation Develops in Two Stages of Clonal Selection , 1998, The Journal of experimental medicine.

[21]  R. Ahmed,et al.  Humoral immunity due to long-lived plasma cells. , 1998, Immunity.

[22]  Bas van Steensel,et al.  TRF2 Protects Human Telomeres from End-to-End Fusions , 1998, Cell.

[23]  D. Broccoli,et al.  Human telomeres contain two distinct Myb–related proteins, TRF1 and TRF2 , 1997, Nature Genetics.

[24]  Andreas Radbruch,et al.  Lifetime of plasma cells in the bone marrow , 1997, Nature.

[25]  Kenneth G. C. Smith,et al.  The extent of affinity maturation differs between the memory and antibody‐forming cell compartments in the primary immune response , 1997, The EMBO journal.

[26]  F. Medina,et al.  Regulatory role of CD95 ligation on human B cells induced in vivo capable of spontaneous and highrate Ig secretion , 1997, European journal of immunology.

[27]  L. Staudt,et al.  Carboxyl-terminal Targeting and Novel Post-translational Processing of JAW1, a Lymphoid Protein of the Endoplasmic Reticulum* , 1996, The Journal of Biological Chemistry.

[28]  J. Banchereau,et al.  Bcl-2+ tonsillar plasma cells are rescued from apoptosis by bone marrow fibroblasts , 1996, The Journal of experimental medicine.

[29]  F. Alt,et al.  Increased T-cell apoptosis and terminal B-cell differentiation induced by inactivation of the Ets-1 proto-oncogene , 1995, Nature.

[30]  N. Muthusamy,et al.  Defective activation and survival of T cells lacking the Ets-1 transcription factor , 1995, Nature.

[31]  A. Lichtenstein,et al.  Myeloma Ig heavy chain V region sequences reveal prior antigenic selection and marked somatic mutation but no intraclonal diversity. , 1995, Journal of immunology.

[32]  U. Storb,et al.  Pip, a novel IRF family member, is a lymphoid-specific, PU.1-dependent transcriptional activator. , 1995, Genes & development.

[33]  R. Ahmed,et al.  Bone marrow is a major site of long-term antibody production after acute viral infection , 1995, Journal of virology.

[34]  W. Reith,et al.  Developmental extinction of major histocompatibility complex class II gene expression in plasmocytes is mediated by silencing of the transactivator gene CIITA , 1994, The Journal of experimental medicine.

[35]  K. Thielemans,et al.  Evidence that the clonogenic cell in multiple myeloma originates from a pre‐switched but somatically mutated B cell , 1994, British journal of haematology.

[36]  Mark M. Davis,et al.  Blimp-1, a novel zinc finger-containing protein that can drive the maturation of B lymphocytes into immunoglobulin-secreting cells , 1994, Cell.

[37]  E. Roldán,et al.  Human tonsil, blood and bone marrow in vivo‐induced B cells capable of spontaneous and high‐rate immunoglobulin secretion in vitro: Differences in the requirements for factors and for adherent and bone marrow stromal cells, as well as distinctive adhesion molecule expression , 1994, European journal of immunology.

[38]  B. Ness,et al.  The bone marrow of multiple myeloma patients contains B cell populations at different stages of differentiation that are clonally related to the malignant plasma cell , 1993, The Journal of experimental medicine.

[39]  M. Boccadoro,et al.  Evidence for a bone marrow B cell transcribing malignant plasma cell VDJ joined to C mu sequence in immunoglobulin (IgG)- and IgA-secreting multiple myelomas , 1993, The Journal of experimental medicine.

[40]  E. Roldán,et al.  VLA-4-fibronectin interaction is required for the terminal differentiation of human bone marrow cells capable of spontaneous and high rate immunoglobulin secretion , 1992, The Journal of experimental medicine.

[41]  J. Tew,et al.  Germinal center B cells and antibody production in the bone marrow. , 1991, Journal of immunology.

[42]  A. Barberis,et al.  A novel B-cell lineage-specific transcription factor present at early but not late stages of differentiation. , 1990, Genes & development.

[43]  R. Benner,et al.  The bone marrow: the major source of serum immunoglobulins, but still a neglected site of antibody formation. , 1981, Clinical and experimental immunology.

[44]  L. Nadler,et al.  Stages of B cell differentiation in human lymphoid tissue , 1981, The Journal of experimental medicine.

[45]  R. Benner,et al.  The mechanism of thymus-dependent antibody formation in bone marrow. , 1981, Journal of immunology.

[46]  B. Barlogie,et al.  Cellular DNA content as a marker of human multiple myeloma. , 1980, Blood.

[47]  C. Morrow,et al.  Characterization of a circulating subpopulation of spontaneous antitetanus toxoid antibody producing B cells following in vivo booster immunization. , 1979, Journal of immunology.

[48]  R. Mcmillan,et al.  Immunoglobulin synthesis by human lymphoid tissues: normal bone marrow as a major site of IgG production. , 1972, Journal of immunology.

[49]  Todd,et al.  Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning , 2002, Nature Medicine.

[50]  Stephen L. Nutt,et al.  Commitment to the B-lymphoid lineage depends on the transcription factor Pax5 , 1999, Nature.

[51]  L. Pilarski,et al.  A high frequency of circulating B cells share clonotypic Ig heavy-chain VDJ rearrangements with autologous bone marrow plasma cells in multiple myeloma, as measured by single-cell and in situ reverse transcriptase-polymerase chain reaction. , 1998, Blood.

[52]  I. Maclennan,et al.  Distinct short‐lived and long‐lived antibody‐producing cell populations , 1986, European journal of immunology.